Cytosurge and Bruker partnership enables FluidFM single cell experiments on BioScope Resolve BioAFM
Date | 2nd, Jul 2018 |
---|---|
Source | News Medical - Scientific News Websites |
DESCRIPTION
Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM technology, and Bruker Corporation, one of the world's leading analytical instrumentation companies, have entered into a new partnership.